HYBRID TELE-REHABILITATION VERSUS CLINIC-BASED THERAPY IN PATIENTS WITH LUMBAR RADICULOPATHY: A RANDOMIZED CONTROLLED TRIAL
HYBRID TELE-REHABILITATION VERSUS CLINIC-BASED THERAPY IN PATIENTS WITH LUMBAR RADICULOPATHY: A RANDOMIZED CONTROLLED TRIAL
A single blinded clinical randomized trial. A single blinded trained investigator examined all patients and collect all data to eliminate inter- investigator error. Patients will be divided according to the treatment procedure into two groups equal in numbers to investigate a comparative effect of hybrid tele-rehabilitation to clinic- based therapy in patients with lumbar radiculopathy.
All patients will sign an informed consent form after receiving information on the purpose of the study, procedure, and possible benefits and risks, privacy and use of data. All patients will be evaluated before training and at the end of the six-week training period with the handheld dynamometry unit for the trunk flexor and extensor muscle strength, Numeric Pain Rating Scale (NPRS) for pain, Oswestry disability index (ODI) for function, Fear avoidance beliefs questionnaire (FABQ) for psychological status and Straight leg raise test (SLR) for sciatic nerve sensitivity.
Inclusion Criteria:
-
1) Both genders will be involved, 2) Symptoms started within more than 4 weeks (Ghasabmahaleh et al., 2021). 3) Patients' age ranges from 25-45 years (Karthick et al., 2024). 4) All patients will be referred by the physician after confirmed diagnosis of lumbar radiculopathy at L4/5 or L5/S1 level through clinical assessment and imaging studies.
5) Patients have sufficient education level. 6) Body mass index for patients will be from 18.5 to 29.9.
Exclusion Criteria:
History of neurological disorders causing radicular pain, 4) Any preexisting injury that may become exacerbated or made worse with participation (Zainab et al., 2022).
5) Cardiovascular problems (unstable angina, recent myocardial infarction within the last three months, congestive heart failure, significant heart valve dysfunction, or unstable hypertension) or pulmonary disorders (Vijayaraj., 2018).